IP Library Patent Application 10514857
Patent Application
App. No. 10/514,857

Macroporous cross-linked polymer particles

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/514,857
Abstract

The present invention relates to a method of producing one or more macroporous cross-linked polymer particles, comprising polymerizing via free radical initiation and cross-linking of bifunctional vinyl ether monomers in an inert solvent that includes ether groups. The invention also relates to particles so produced, which are useful as separation medium e.g. in RPC or, after suitable derivatisation, in other chromatographic methods.

Claims (16)

1 . A method of producing one or more macroporous cross-linked polymer particles, comprising polymerizing via free radical initiation and cross-linking of bifunctional vinyl ether monomers in an inert solvent that includes ether groups.

2 . The method of claim 1 , wherein the ether groups are polyether groups.

3 . The method of claim 1 , wherein the solvent is a mixture of an ether and/or polyether solvent and an alcoholic solvent.

4 . The method of claim 3 , wherein each polymer of the polyether solvent exhibits a molecular weight above about 60 g/mole.

5 . The method of claim 4 , wherein the polyether solvent is selected from the group consisting of poly(ethylene glycol) (PEG), poly(propylene glycol) (PPG), and mixtures comprising PEG and/or PPG.

6 . The method of claim 5 , wherein the polyether solvent is polypropylene glycol (PPG).

7 . The method of claim 1 , wherein the bifunctional vinyl ether monomers are linear or cyclic alkyl divinyl ether monomers.

8 . The method of claim 7 , wherein the vinyl ether monomers are selected from the group consisting of cyclohexanedimethanol divinyl ether monomers and mixtures, thereof.

9 . The method of claim 7 , wherein the vinyl ether monomers are selected from the group consisting of diethyleneglycol divinyl ether monomers, or a mixture thereof.

10 . The method of claim 7 , wherein the divinyl ether monomers are polymerised and cross-linked with at least one other monomer which is a bifunctional monomer comprising two vinyl groups.

11 . The method of claim 7 . wherein the divinyl ether monomers are polymerised with at least one other monomer which is a monofunctional monomer including one vinyl group.

12 . The method of claim 11 , wherein said other monomers include at least one non-vinyl functional group.

13 . The method of claim 1 wherein the polymerizing is via a suspension polymerisation.

14 . The method of claim 1 , further comprising modifying the surface of the particles produced by derivatisation of residual vinyl groups.

15 . A macroporous cross-linked polymer particle, which has been produced by the method of claim 1 .

16 - 17 . (canceled)

Assignments (2)
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2004
From: SODERMAN, TOBIAS
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015403/0061 →